Diality Inc., a medical device company headquartered in Irvine, Calif., has appointed Ravi Parthasarathy as its new Chief Technology Officer. With extensive experience in product development team leadership, Parthasarathy previously worked at ICU Medical as the Vice President of Device Engineering. Prior to that, he held leadership positions at Baxter Healthcare, Motorola, Siemens Medical Systems, and General Motors.
As Diality continues to grow, Osman Khawar, M.D., the CEO of the company, expressed his excitement about Parthasarathy joining the team. He stated that Parthasarathy’s expertise and alignment with Diality’s mission, vision, and values make him an ideal fit for the company. Additionally, Clayton Poppe will transition into the role of Chief Scientific Officer (CSO), overseeing research, quality, and regulatory functions.
Parthasarathy expressed his enthusiasm about joining Diality and cites the company’s mission of improving the lives of those affected by kidney disease as a significant motivation. The Moda-flxTM Hemodialysis System developed by Diality is a patient-centric solution designed to empower healthcare professionals to make choices that benefit patients and their clinical practice.
Diality is committed to delivering innovative solutions that improve the quality of life for dialysis patients. The Moda-flxTM Hemodialysis System is currently in development and aims to address the needs of both patients and healthcare providers. For more information about Diality and its products or media inquiries, please visit www.diality.com or contact Sam Choinski at schoinski@pazangahealth.com or (860) 301-5058.
